President Donald Trump has secured a sweeping set of drug pricing concessions that reach deep into both Medicare and Medicaid, reshaping how some of the most expensive medicines will be paid for in ...

U.S. President Donald Trump, Eli Lilly (LLY.N) and Novo Nordisk (NOVOb.CO) signed a deal in November to slash the prices of ...

The Trump administration introduced Tuesday a new drug pricing model that seeks to allow Medicare Part D plans and state Medicaid agencies to cover GLP-1s, potentially expanding coverage for the ...

The Trump administration has unveiled yet another new payment model, this one focused on the cost of GLP-1 therapies. | The Trump administration has unveiled yet another new payment model, this one ...

CMS released plans Dec. 23 for its voluntary “Better Approaches to Lifestyle and Nutrition for Comprehensive hEalth” — or BALANCE — model. The announcement comes weeks following the White House’s ...

CMS published plans Dec. 23 for its voluntary “Better Approaches to Lifestyle and Nutrition for Comprehensive hEalth” — or BALANCE — model. The announcement comes weeks following the White House’s ...

Altimmune's pemvidutide shows strong Phase IIb results for MASH, promising Phase III prospects. Read here for more analysis ...

Conclusions Cognitive impairment is associated with increased risks of cardiovascular death and composite cardiovascular outcomes. Uncontrolled lifestyle, cardiometabolic and psychological risk ...